Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
BMS-184476 Bristol-Myers SquibbIwao Ojima, Raphaël GeneyCurrent Opinion in Investigational Drugs (London, England : 2000)|August 7, 2003
109881 AventisIwao Ojima, Raphaël GeneyAnti-Cancer Agents in Medicinal Chemistry|October 26, 2012
Type II kinase inhibitors: an opportunity in cancer for rational designJavier Blanc, Raphaël Geney, Christel MenetProgress in Medicinal Chemistry|February 7, 2013
Advances in the discovery of selective JAK inhibitorsChristel J Menet, Luc Van Rompaey, Raphaël GeneyClinical Chemistry and Laboratory Medicine|November 19, 2002
Overcoming multidrug resistance in taxane chemotherapyRaphaël Geney, loana Maria Ungureanu, Dansu Li, et al.Journal of Chemical Theory and Computation|December 3, 2015
Investigation of Salt Bridge Stability in a Generalized Born Solvent ModelRaphaël Geney, Melinda Layten, Roberto Gomperts, et al.Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Design and synthesis of de novo cytotoxic alkaloids through mimicking taxoid skeletonXudong Geng, Raphaël Geney, Paula Pera, et al.Chirality|February 9, 2002
Electronic effects on the regio- and enantioselectivity of the asymmetric aminohydroxylation of O-substituted 4-hydroxy-2-butenoatesChih-Yuan Chuang, Victor C Vassar, Zuping Ma, et al.Chemistry & Biology|March 31, 2005
Use of the tubulin bound paclitaxel conformation for structure-based rational drug designRaphaël Geney, Liang Sun, Paula Pera, et al.The Journal of Organic Chemistry|November 4, 2008
Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoidsLiang Sun, Xudong Geng, Raphaël Geney, et al.Pageof 2